Are children with SARS‐CoV‐2 infection at high risk for thrombosis? Viscoelastic testing and coagulation profiles in a case series of pediatric patients
Open Access
- 24 October 2020
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 67 (12) , e28737
Abstract
The coagulopathy of the novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is well documented in adults, with increases in D‐dimer and prothrombin time found to be strong predictors of mortality, and anticoagulation shown to decrease this mortality. Viscoelastic parameters such as elevations in maximum clot firmness (MCF) on rotational thromboelastometry (ROTEM) have correlated with a hypercoagulable state in adults with SARS‐CoV‐2. We report our experience in children infected with SARS‐CoV‐2, with noted elevations in D‐dimer and MCF on ROTEM (indicating hypercoagulability). Exploration of viscoelastic testing to provide additional laboratory‐based evidence for pediatric‐specific risk assessment for thromboprophylaxis in SARS‐CoV‐2 is warranted.Keywords
All Related Versions
This publication has 15 references indexed in Scilit:
- Are children with SARS‐CoV‐2 infection at high risk for thrombosis? Viscoelastic testing and coagulation profiles in a case series of pediatric patientsPediatric Blood & Cancer, 2020
- Hypofibrinolytic state and high thrombin generation may play a major role in SARS‐COV2 associated thrombosisJournal of Thrombosis and Haemostasis, 2020
- The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndromeJournal of Thrombosis and Haemostasis, 2020
- Incidence of thrombotic complications in critically ill ICU patients with COVID-19Thrombosis Research, 2020
- COVID-19 and its implications for thrombosis and anticoagulationBlood, 2020
- D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19Journal of Thrombosis and Haemostasis, 2020
- Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19Journal of Thrombosis and Haemostasis, 2020
- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathyJournal of Thrombosis and Haemostasis, 2020
- COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory FailureThrombosis and Haemostasis, 2020
- Thromboelastometry (ROTEM®) in children: age-related reference ranges and correlations with standard coagulation testsBritish Journal of Anaesthesia, 2010